In human clinical studies, administration of M. pruriens proved to be rapidly acting
with longer ‘‘ON” periods without concomitant increase in dyskinesis, suggesting that this natural source of L-DOPA might possess advantages over conventional L-DOPA preparations in the longterm
management of the disease